<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03667859</url>
  </required_header>
  <id_info>
    <org_study_id>0398-18-RMB</org_study_id>
    <nct_id>NCT03667859</nct_id>
  </id_info>
  <brief_title>Vaginal Elasticity Assessment Before and After Brachytherapy/Pelvic Radiation</brief_title>
  <official_title>Vaginal Elasticity Assessment Before and After Brachytherapy/Pelvic Radiation as Measured by Vaginal Tactile Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Female patients with either uterine/cervical malignancies will be evaluated for vaginal
      elasticity using vaginal tactile imaging both before and after radiation treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be recruited and sign a consent form. The patients included are patients with
      either uterine/cervical malignancies. Each participant undergoes radiation treatment either
      as primary or complementary treatment.

      Assessment of vaginal elasticity via vaginal tactile imaging will be performed at 3 different
      points:

        -  Before the first treatment session (baseline).

        -  After the last session of laser treatment.

        -  3 months post final treatment. Every patient will serve as her own control. Demographic,
           gynecologic and obstetric history will be obtained from patients` electronic files.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal elasticity assessment</measure>
    <time_frame>up to 6 months from enrollment</time_frame>
    <description>Vaginal elasticity as measured by the vaginal tactile imager.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Radiation Injuries</condition>
  <arm_group>
    <arm_group_label>Women undergoing Brachytherapy</arm_group_label>
    <description>Women with either uterine or cervical malignancy treated primarily by brachytherapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Women undergoing Pelvic Radiation</arm_group_label>
    <description>Women with either uterine or cervical malignancy treated primarily by pelvic radiation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vaginal Tactile Imaging</intervention_name>
    <description>Vaginal elasticity measurements using the Vaginal Tactile Imaging system.</description>
    <arm_group_label>Women undergoing Brachytherapy</arm_group_label>
    <arm_group_label>Women undergoing Pelvic Radiation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing either brachytherapy or pelvic radiation treatment as primary or
        complementary treatment for a cervical/uterine malignancy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any woman undergoing either brachytherapy or pelvic radiation treatment as primary or
             complementary treatment for a cervical/uterine malignancy.

        Exclusion Criteria:

          -  Women that are not in the age range.

          -  Women with massive vaginal bleeding.

          -  Women after pelvic exenteration.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female patients with gynecological malignancies.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Roy Lauterbach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roy Lauterbach, MD</last_name>
    <phone>0529432416</phone>
    <email>r_lauterbach@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam health care campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Lauterbach, MD</last_name>
      <phone>0529432416</phone>
      <email>r_lauterbach@rambam.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>September 10, 2018</study_first_submitted>
  <study_first_submitted_qc>September 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2018</study_first_posted>
  <last_update_submitted>December 12, 2019</last_update_submitted>
  <last_update_submitted_qc>December 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>ROY LAUTERBACH MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiation Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

